Search Results - Vapaatalo, Mirja

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Rituximab Maintenance Bimonthly for Two Years after Prolonged Immunochemotherapy in Elderly Patients with Mantle Cell Lymphoma (MCL) Results in Long Remissions: Update with Six-Year Follow-up of a Prospective Study By the Finnish Lymphoma Group

    Rituximab Maintenance Bimonthly for Two Years after Prolonged Immunochemotherapy in Elderly Patients with Mantle Cell Lymphoma (MCL) Results in Long Remissions: Update with Six-Yea... by Räty, Riikka, Honkanen, Tuomo, Jantunen, Esa, Jyrkkiö, Sirkku, Karjalainen-Lindsberg, Marja-Liisa, Kuittinen, Outi, Lehto, Minna, Mikkola, Maija, Poikonen, Eira, Rauhala, Auvo, Rimpiläinen, Johanna, Räsänen, Anu, Siitonen, Sanna, Suominen, Merja, Vapaatalo, Mirja, Elonen, Erkki

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Imatinib and pegylated IFN-alpha 2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response

    Imatinib and pegylated IFN-alpha 2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response by Koskenvesa, Perttu, Kreutzman, Anna, Rohon, Peter, Pihlman, Markus, Vakkila, Emmi, Rasanen, Anu, Vapaatalo, Mirja, Remes, Kari, Lundan, Tuija, Hjorth-Hansen, Henrik, Vakkila, Jukka, Simonsson, Bengt, Mustjoki, Satu, Porkka, Kimmo

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response

    Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response by Koskenvesa, Perttu, Kreutzman, Anna, Rohon, Peter, Pihlman, Markus, Vakkila, Emmi, Räsänen, Anu, Vapaatalo, Mirja, Remes, Kari, Lundán, Tuija, Hjorth-Hansen, Henrik, Vakkila, Jukka, Simonsson, Bengt, Mustjoki, Satu, Porkka, Kimmo

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group

    Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance i... by Räty, Riikka, Honkanen, Tuomo, Jantunen, Esa, Jyrkkiö, Sirkku, Karjalainen-Lindsberg, Marja-Liisa, Kuittinen, Outi, Lehto, Minna, Mikkola, Maija, Poikonen, Eira, Rauhala, Auvo, Rimpiläinen, Johanna, Räsänen, Anu, Siitonen, Sanna, Suominen, Merja, Vapaatalo, Mirja, Elonen, Erkki

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Imatinib and pegylated IFN ‐ α 2b discontinuation in first‐line chronic myeloid leukemia patients following a major molecular response

    Imatinib and pegylated IFN ‐ α 2b discontinuation in first‐line chronic myeloid leukemia patients following a major molecular response by Koskenvesa, Perttu, Kreutzman, Anna, Rohon, Peter, Pihlman, Markus, Vakkila, Emmi, Räsänen, Anu, Vapaatalo, Mirja, Remes, Kari, Lundán, Tuija, Hjorth‐Hansen, Henrik, Vakkila, Jukka, Simonsson, Bengt, Mustjoki, Satu, Porkka, Kimmo

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Imatinib Discontinuation Following a Major Molecular Response: Impact of Interferon Alpha and Leukemia Stem Cell Burden (The STOP Study)

    Imatinib Discontinuation Following a Major Molecular Response: Impact of Interferon Alpha and Leukemia Stem Cell Burden (The STOP Study) by Koskenvesa, Perttu, Mustjoki, Satu, Räsänen, Anu, Vapaatalo, Mirja, Remes, Kari, Lundán, Tuija, Vakkila, Jukka, Simonsson, Bengt, Porkka, Kimmo

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Elderly Patients with Mantle Cell Lymphoma (MCL) – Efficacy and Feasibility of Prolonged Immunochemotherapy with Rituximab, Cytarabine and Fludarabine Added to CHOP and Followed by Rituximab Maintenance Treatment. A Prospective Study by the Finnish Lymphoma Group

    Elderly Patients with Mantle Cell Lymphoma (MCL) – Efficacy and Feasibility of Prolonged Immunochemotherapy with Rituximab, Cytarabine and Fludarabine Added to CHOP and Followed by... by Elonen, Erkki, Räty, Riikka, Honkanen, Tuomo, Jantunen, Esa, Jyrkkiö, Sirkku, Karjalainen-Lindsberg, Marja-Liisa, Kuittinen, Outi, Lehto, Minna, Poikonen, Eira, Rauhala, Auvo, Rimpiläinen, Johanna, Räsänen, Anu, Siitonen, Sanna, Suominen, Merja, Vapaatalo, Mirja

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: